Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of MAT9001 vs Omega-3 Comparator in Hypertriglyceridemia
NCT02310022Phase 2Completed
- Sponsor
- Matinas BioPharma
- Start
- Nov 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MAT9001 in hypertriglyceridemia, sponsored by Matinas BioPharma. Started Nov 2014; status: completed.
02
Drugs
MAT9001
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT02310022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02310022.